11ukM

London Quick Take - 7 August - Trump isn’t chickening out, US tech doesn’t care, Bank of England to cut

Equities 3 minutes to read
Neil Wilson
Neil Wilson

Investor Content Strategist

Note: This is marketing material. This article is not investment advice, capital is at risk.

Key Points

  • Trump threatens 100% tariffs on semiconductors
  • Apple gains 5% after increasing US investment by $100bn
  • WPP shares slump on earnings
  • Bank of England expected to cut rates today

No Taco: Trump hit India with an extra 25% tariff for its purchase of Russian oil, and 100% tariffs on semiconductor imports, unless firms commit to moving production to the US.

Apple CEO Tim Cook was by the President’s side for the announcement. Apple shares ripped higher as it committed to invest another $100bn in the US, on top of its $500bn commitment already announced. Tariff risk reduced but does it boost sales, or lower costs? Apple has already warned of $1.1bn in tariff costs in the September quarter, but moving production to the US will clearly hit margins. Carve-outs will help Nvidia and Taiwan Semiconductor Manufacturing Company (TSMC), which have made sure to commit many billions of dollars to US manufacturing. The broad reciprocal tariffs announced last week are now in place.

Amazon also rose 4% as tech stocks rallied to lift Wall Street, with the S&P 500 up 0.73% to 6,345 and the Nasdaq Composite climbing 1.21%. The S&P 500 has filled the Thu/Fri gap and is back above its 20-day moving average. Small caps fell with the Russell 2k down 0.2%.

The new tariffs on India mean it will be paying 50% on imports to the US. Not a massive deal for the economy – about 2% of GDP is exports to the US – but the wider implication is obvious – Trump is not shying away from further ratcheting of tariffs if he feels it’s required.

In Europe on Thursday, Frankfurt and Paris are higher while London is lower. The FTSE 100 slid about 0.3% early doors due chiefly to a chunk of ex-divis, with AZN accounting for 5pts alone. Reckitt took over 2pts off the index while RELX, BT, Barclays and Rolls each shaved about 1.5pts off. Hikma led the actual fallers, shipping about 8% after profits plunged 25%. WPP was the next worst, down over 4% on weak results.

The Bank of England meeting today is expected to bring a 25 basis rate cut, but perhaps more important is any word on slowing pace of bond sales (QT), which could be a dovish tilt. Sterling has put in a shift versus the weaker USD over the last few sessions, posting a new 6-day high above 1.3370 overnight. Against the stronger euro it’s another matter with sterling battling resistance at 0.8735. Preview here.
WPP - no good news, results certainly offer no improvement from the July update. Shares down –4% and now 50% in the last 6 months. Today’s interims come after the stock sunk to a 16-year low following a massive profit warning last month. It’s battling huge structural storms in the ad industry. In July it warned first-half like-for-like revenue would fall between 4.2% and 4.5% as Q2 fell further behind last year than Q1. WPP confirmed today that Q2 revenues less pass-through costs was down 12.6%, leaving H1 revenues on that basis down 4.3%. Full-year revenue is still guided to fall 3% to 5%, from a previous forecast of a decline of no more than 2%. 

Disney beat and raised but shares fell. Parks look good and it swung to profits from its streaming business. It raised the full-year EPS forecast to $5.85, up from its May forecast of $5.75, but a sharp decline in its linear TV business dragged on sentiment.

Uber announced a $20bn share buyback but also fell. Revenues rose 18%, monthly active users rose 15%, net income rose by a third to $1.4bn, and the company lifted its gross bookings guidance for the current quarter ahead of expectations. Shares have rallied a lot this year and maybe just a case of all the good news baked in and investors can’t shrug off feeling that consumer softness in the US will be a factor whatever CEO Dara Khosrowshahi says.

McDonald’s sales returned to growth with global same-store sales up 3.8% vs the 2.6% expected.

Novo Nordisk can’t catch a break – tough to make a call on this while the plug is still out of the bath....new CEO comes in but compounded copycat problem remains, Trump is threatening tariffs of 250% on pharmaceutical sector and its next-generation obesity drug candidate, CagriSema, is not delivering the trial results its needs to. 

Quarterly Outlook

01 /

  • Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Quarterly Outlook

    Q3 Investor Outlook: Beyond American shores – why diversification is your strongest ally

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    Quarterly Outlook

    Q3 Macro Outlook: Less chaos, and hopefully a bit more clarity

    John J. Hardy

    Global Head of Macro Strategy

    After the chaos of Q2, the quarter ahead should get a bit more clarity on how Trump 2.0 is impacting...
  • Equity outlook: The high cost of global fragmentation for US portfolios

    Quarterly Outlook

    Equity outlook: The high cost of global fragmentation for US portfolios

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: Commodities rally despite global uncertainty

    Quarterly Outlook

    Commodity Outlook: Commodities rally despite global uncertainty

    Ole Hansen

    Head of Commodity Strategy

  • Upending the global order at blinding speed

    Quarterly Outlook

    Upending the global order at blinding speed

    John J. Hardy

    Global Head of Macro Strategy

    We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ...
  • Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Quarterly Outlook

    Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever

    Jacob Falkencrone

    Global Head of Investment Strategy

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Markets UK Ltd. (Saxo) and the Saxo Bank Group provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation. Access and use of this website is subject to: (i) the Terms of Use; (ii) the full Disclaimer; (iii) the Risk Warning; and (iv) any other notice or terms applying to Saxo’s news and research.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer for more details. Past Performance is not indicative of future results.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992